Who are Cimicifuga + Hiperico's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): BNO 1016, Sinupret extract coated tablets, Passiflora ; Crataegus and Salix.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cimicifuga-hiperico.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Cimicifuga + Hiperico — Competitive Intelligence Brief

Cimicifuga + Hiperico (Cimicifuga + Hiperico) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal combination / phytotherapeutic agent. Area: Women's Health / Menopause.

phase 3 Herbal combination / phytotherapeutic agent Women's Health / Menopause Small molecule Live · refreshed every 30 min

Target snapshot

Cimicifuga + Hiperico (Cimicifuga + Hiperico) — Phytopharm Consulting Brazil. This herbal combination product uses Cimicifuga (black cohosh) and Hypericum (St. John's Wort) to modulate serotonergic and hormonal pathways, potentially alleviating menopausal symptoms and mood disturbances.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Cimicifuga + Hiperico TARGET	Cimicifuga + Hiperico	Phytopharm Consulting Brazil	phase 3	Herbal combination / phytotherapeutic agent
BNO 1016	BNO 1016	Bionorica SE	phase 3	Herbal combination / Phytotherapeutic agent
Sinupret extract coated tablets	Sinupret extract coated tablets	Bionorica SE	phase 3	Herbal combination / phytotherapeutic agent
Passiflora ; Crataegus and Salix	Passiflora ; Crataegus and Salix	Marjan Industria e Comercio ltda	phase 3	Herbal combination / Phytotherapeutic agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal combination / phytotherapeutic agent class)

Bionorica SE · 1 drug in this class
Phytopharm Consulting Brazil · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cimicifuga + Hiperico — Competitive Intelligence Brief. https://druglandscape.com/ci/cimicifuga-hiperico. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab